最新の財務諸表(Form-10K)によると、abrdn World Healthcare Fundの総資産は$637で、純利益は$55です。
THWの主要な財務比率は何ですか?
abrdn World Healthcare Fundの流動比率は5.13、純利益率は500、1株当たり売上高は$0.27です。
abrdn World Healthcare Fundの収益はセグメントまたは地域別にどのように分けられていますか?
現在、abrdn World Healthcare Fund のデータは利用できません。
abrdn World Healthcare Fundは収益を上げていますか?
はい、最新の財務諸表によると、abrdn World Healthcare Fundの純利益は$55です。
abrdn World Healthcare Fundに負債はありますか?
はい、abrdn World Healthcare Fundの負債は124です。
abrdn World Healthcare Fundの発行済株式数は何株ですか?
abrdn World Healthcare Fundの総発行済株式数は40株です。
主要データ
前終値
$11.81
始値
$11.73
当日レンジ
$11.68 - $11.84
52週レンジ
$9.8 - $13.19
取引高
104.9K
平均取引高
165.9K
配当利回り
5.73%
1株当たり利益(TTM)
1.35
時価総額
$472.4M
THWとは何ですか?
abrdn World Healthcare Fund is a US-based company operating in industry. The company is headquartered in Philadelphia, Pennsylvania. The company went IPO on 2015-06-26. abrdn World Healthcare Fund (the Fund), formerly Tekla World Healthcare Fund, is a non-diversified closed-end management investment company. The Fund's investment objective is to seek current income and long-term capital appreciation. The Fund invests primarily in equity and debt securities of public and private United States and non-United States companies. The Fund is focused on investing at least 40% of its managed assets in companies organized or located outside the United States or companies that do a substantial amount of business outside the United States. The Fund may invest up to 20% of managed assets, measured at the time of investment, in non-convertible debt of healthcare companies. The Fund may also invest up to 20% of managed assets in healthcare real estate investment trusts. The Fund invests in sectors, which include biotechnology, pharmaceuticals, healthcare equipment, healthcare supplies, healthcare distributors, and others. The Fund’s investment adviser is abrdn Inc.